Safety of tacrolimus in pregnancy

Will Nevers, Anna Pupco, Gideon Koren, Pina Bozzo

פרסום מחקרי: פרסום בכתב עתסקירהביקורת עמיתים

44 ציטוטים ‏(Scopus)

תקציר

Question: I have a 30-year-old patient who had a kidney transplant 2 years ago. She is now planning a pregnancy. She has been treated with tacrolimus since her transplant. Will it be safe for the fetus if she continues to take it during the pregnancy or should she switch to a different antirejection medication?

Answer If your patient is stable while taking tacrolimus, there is no reason to switch. The current available information does not suggest that tacrolimus increases the risk of major congenital malformations above the baseline risk in the general population. Premature birth and low birth weight are often reported in this population; however, these effects are frequently reported in pregnant transplant patients treated with other immunosuppressant agents and probably reflect the effects of the maternal condition. As there are some reports of hyperkalemia and renal impairment in infants exposed to tacrolimus in utero, kidney function and electrolytes should be monitored in exposed neonates.

שפה מקוריתאנגלית
עמודים (מ-עד)905-906
מספר עמודים2
כתב עתCanadian Family Physician
כרך60
מספר גיליון10
סטטוס פרסוםפורסם - 1 אוק׳ 2014
פורסם באופן חיצוניכן

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'Safety of tacrolimus in pregnancy'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי